Exploring The Structure and Function of RS9_HUMAN (G6203)

Target Name: RPS9

NCBI ID: G6203

RPS9

Exploring The Structure and Function of RS9_HUMAN

RNA-protein interactions are a critical mechanism in many cellular processes, including protein synthesis, degradation, and signaling. RS9_HUMAN, also known as RPS9, is a protein that has been identified as a potential drug target or biomarker in the context of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will explore the structure and function of RS9_HUMAN, and discuss its potential as a drug target or biomarker.

Structure and Localization

RS9_HUMAN is a 9 kDa protein that is expressed in most tissues of the human body. It is localized to the endoplasmic reticulum (ER) and cytoplasm, and has been shown to be involved in various cellular processes, including protein synthesis, folding, and degradation. RS9_HUMAN is composed of a unique fusion protein that consists of a N-terminal cytosine residue, a catalytic alpha-helices, and a C-terminal glycine residue.

Function

RS9_HUMAN is involved in the regulation of protein synthesis and degradation in the ER. It has been shown to play a role in the export of proteins from the ER to the cytoplasm, and is required for the proper functioning of protein synthesis and degradation in the ER. Additionally, RS9_HUMAN has been shown to be involved in the regulation of protein folding and stability, which are critical processes that play a central role in the regulation of protein function and stability.

Drug Target Potential

The potential drug target status of RS9_HUMAN is supported by several studies that have shown that it is involved in various cellular processes that are associated with the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, several studies have shown that RS9_HUMAN is involved in the regulation of cellular processes that are associated with the development of cancer, including cell growth, apoptosis, and angiogenesis. Additionally, RS9_HUMAN has been shown to be involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, and has been shown to play a role in the regulation of autoimmune disorders.

Biomarker Potential

The potential use of RS9_HUMAN as a biomarker in disease diagnosis and treatment is also supported by several studies. For example, several studies have shown that RS9_HUMAN is involved in the regulation of cellular processes that are associated with the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, RS9_HUMAN has been shown to be expressed in various tissues and cells of the body, which suggests that it may be a useful biomarker for disease diagnosis and treatment.

Conclusion

RS9_HUMAN is a unique protein that is involved in various cellular processes that are critical for the regulation of protein synthesis and degradation in the ER. Its potential as a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders is supported by several studies. Further research is needed to fully understand the role of RS9_HUMAN in these diseases and to develop effective treatments based on its potential as a drug target or biomarker.

Protein Name: Ribosomal Protein S9

Functions: Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797)

The "RPS9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets